PT Diastika Biotekindo Tbk (ISX:CHEK) Marketable Securities: Rp0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PT Diastika Biotekindo Tbk Marketable Securities?

PT Diastika Biotekindo Tbk ISX:CHEK -0.74% Marketable Securities is Rp0.00 Mil as of . 20. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. PT Diastika Biotekindo Tbk's Marketable Securities for the quarter that ended in . 20 was Rp0.00 Mil.

PT Diastika Biotekindo Tbk  (ISX:CHEK) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

PT Diastika Biotekindo Tbk Marketable Securities Related Terms

PT Diastika Biotekindo Tbk Marketable Securities Historical Data

* Premium members only.

The historical data trend for PT Diastika Biotekindo Tbk's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Diastika Biotekindo Tbk Marketable Securities Chart

PT Diastika Biotekindo Tbk Annual Data
Trend
Marketable Securities

PT Diastika Biotekindo Tbk Semi-Annual Data
Marketable Securities

PT Diastika Biotekindo Tbk Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of Rp0.00 Mil mean?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a Marketable Securities of Rp0.00 Mil as of . 20. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Diastika Biotekindo Tbk and its competitors.
Is PT Diastika Biotekindo Tbk's Marketable Securities too high?
PT Diastika Biotekindo Tbk's current Marketable Securities is Rp0.00 Mil.
How does PT Diastika Biotekindo Tbk's Marketable Securities compare to MCK and COR?
PT Diastika Biotekindo Tbk's Marketable Securities of Rp0.00 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Distribution company?
A good Marketable Securities depends on the Medical Distribution industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on PT Diastika Biotekindo Tbk and its competitors. PT Diastika Biotekindo Tbk's current Marketable Securities is Rp0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Diastika Biotekindo Tbk stock overvalued right now?
PT Diastika Biotekindo Tbk (ISX:CHEK) has a current Marketable Securities of Rp0.00 Mil. The current Marketable Securities is Rp0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For PT Diastika Biotekindo Tbk (ISX:CHEK), the current Marketable Securities is Rp0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Diastika Biotekindo Tbk Business Description

Address Jalan Rawagelam V, Kawasan Industri Pulogadung, Block L, No. Kav 11-13, Gedung Etana Lantai 3, Desa/Kelurahan Jatinegara, Kec. Cakung, Kota Adm. Jakarta Timur, Jakarta, IDN, 13930
PT Diastika Biotekindo Tbk is engaged in providing medical and laboratory equipment solutions in Indonesia. It is engaged in the wholesale trading of laboratory equipment, pharmaceutical products, and medical devices for human use. The company is also involved in wholesale trading of radioactive substances and ionizing radiation generators, and undertakes activities related to the testing and/or calibration of medical devices, as well as the inspection of healthcare facilities and infrastructure. Its product offerings mainly include devices like hematology analyzer, pipette, hemoglobin testing system, etc. The company's operating segments are: Diagnostics Group, which generates the maximum revenue, and Life Sciences Group. Geographically, all of its revenue is derived from Indonesia.